Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary angiosarcoma of the spleen.

Jun-Te Hsu1, Han-Ming Chen, Chin-Yew Lin

  • 1Department of General Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

Journal of Surgical Oncology
|November 22, 2005
PubMed
Summary

Primary splenic angiosarcoma is a rare cancer. This study reports six cases, finding splenomegaly common and highlighting potential long-term survival after splenectomy alone.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updated Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor (2025).

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2026
Same author

Dose-Expansion Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors.

The oncologist·2026
Same author

Corrigendum to "Androgen receptor may promote tumor progression via TTF-1/EGFR pathway in metastatic nasopharyngeal carcinoma" [Translational Oncology, Volume 65, March 2026, 102670].

Translational oncology·2026
Same author

Hand-foot skin reaction as a positive prognostic factor in vascular endothelial growth factor receptor-tyrosine kinase inhibitor treatment.

British journal of pharmacology·2026
Same author

A nomogram for predicting recurrence-free survival in patients with high-risk GIST receiving adjuvant imatinib: A nationwide registry study.

Experimental and therapeutic medicine·2026
Same author

Risk Stratification in Papillary Thyroid Microcarcinoma: Clinical Features Predicting Multifocality, Lymph Node Metastasis, and Recurrence - A Retrospective Cohort Study.

Cancer management and research·2026

Area of Science:

  • Oncology
  • Pathology
  • Surgical Oncology

Background:

  • Primary splenic angiosarcoma is an exceptionally rare and aggressive vascular neoplasm.
  • It is characterized by a high propensity for metastasis and a poor prognosis.
  • Limited case reports necessitate further clinical data for understanding and treatment.

Purpose of the Study:

  • To report six additional cases of primary splenic angiosarcoma.
  • To analyze the clinical presentation, treatment, and outcomes of these patients.
  • To contribute to the limited medical literature on this rare malignancy.

Main Methods:

  • Retrospective review of primary splenic angiosarcoma cases treated at Chang Gung Memorial Hospital (April 1991 - July 2004).
  • Analysis of patient demographics, clinical symptoms, hematological findings, and imaging data.

Related Experiment Videos

  • Evaluation of treatment modalities (splenectomy, hepatectomy, chemotherapy) and survival rates.
  • Main Results:

    • Six cases (3 male, 3 female; age 7-69) were identified, with common symptoms including abdominal masses/pain, fatigue, and weight loss.
    • Splenomegaly was universal; anemia and thrombocytopenia were frequent hematological findings.
    • At diagnosis or post-therapy, metastasis to liver, bone, and bone marrow occurred. Survival rates at 1, 3, and 5 years were 60%, 40%, and 40%, respectively, with a median survival of 36 months.

    Conclusions:

    • Clinical presentation aligns with prior reports, with a notable increase in splenomegaly incidence.
    • Splenectomy alone may lead to long-term disease-free survival, even in adult cases.
    • This study adds valuable data on the management and prognosis of primary splenic angiosarcoma.